Fumaric-acid esters (Fumaderm (R)) for severe, treatment resistant psoriasis: a prospective, open-label study.

Research output: Contribution to journal › Poster abstract

3 Citations (Scopus)

Original language	English
Pages (from-to)	U29 - U29
Journal	British Journal of Dermatology
Volume	154
Issue number	1
Publication status	Published - 2006
Event	Psoriasis: from gene to clinic. 4th International congress. - London, England, United Kingdom Duration: 1 Dec 2005 → 3 Dec 2005

Cite this

@article{eec7dd68cda54844bb231fd67792949b,

title = "Fumaric-acid esters (Fumaderm (R)) for severe, treatment resistant psoriasis: a prospective, open-label study.",

author = "Smith, {C H} and E Jones and M Wain and Barker, {J N W N}",

year = "2006",

language = "English",

volume = "154",

pages = "U29 -- U29",

journal = "British Journal of Dermatology",

issn = "1365-2133",

publisher = "John Wiley & Sons, Ltd (10.1111)",

number = "1",

note = "Psoriasis: from gene to clinic. 4th International congress. ; Conference date: 01-12-2005 Through 03-12-2005",

}

TY - JOUR

T1 - Fumaric-acid esters (Fumaderm (R)) for severe, treatment resistant psoriasis: a prospective, open-label study.

AU - Smith, C H

AU - Jones, E

AU - Wain, M

AU - Barker, J N W N

PY - 2006

Y1 - 2006

M3 - Poster abstract

SN - 1365-2133

VL - 154

SP - U29 - U29

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

T2 - Psoriasis: from gene to clinic. 4th International congress.

Y2 - 1 December 2005 through 3 December 2005

ER -